Sign Up to like & get
recommendations!
0
Published in 2017 at "International journal of pharmaceutics"
DOI: 10.1016/j.ijpharm.2017.06.045
Abstract: This study describes the development of new mannosylated Solid Lipid Nanoparticle assemblies (SLNas) delivering rifampicin for an inhaled treatment of tuberculosis. SLNas were surface engineered with mannose residues to recognize mannose receptors located on infected…
read more here.
Keywords:
active targeting;
nanoparticle assemblies;
methyl mannopyranoside;
lipid nanoparticle ... See more keywords